Seeing Is Believing

Currently out of the existing stock ratings of Greg Harrison, 107 are a BUY (69.93%), 34 are a HOLD (22.22%), 12 are a SELL (7.84%).
Analyst Greg Harrison, currently employed at BAML, carries an average stock price target met ratio of 58.02% that have a potential upside of 38.7% achieved within 156 days.
Greg Harrison’s has documented 299 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UTHR, United Therapeutics at 30-Mar-2026.
Analyst best performing recommendations are on OMER (OMEROS).
The best stock recommendation documented was for APLS (APELLIS PHARMACEUTICALS) at 7/30/2025. The price target of $22 was fulfilled within 1 day with a profit of $3 (15.79%) receiving and performance score of 157.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6.25
$6.24 (62400.00%)
$25
4 years 5 months 1 days ago
(23-May-2022)
1/3 (33.33%)
$0.9 (16.82%)
14
Buy
$11
5 years 8 months 7 days ago
(17-Feb-2021)
1/1 (100%)
$-23.25 (-67.88%)
998
Buy
$125
$124.57 (28969.77%)
6 years 5 months 16 days ago
(08-May-2020)
0/1 (0%)
$54 (76.06%)
What Year was the first public recommendation made by Greg Harrison?